One case met the criteria for Hy’s Law8 on the control arm; 23/203 (11.3%) participants receiving experimental regimens had a peak ALT of >5xULN, compared to 4/68 (5.9%) participants receiving standard TB treatment. This evidence concerns the gene GPT and tuberculosis.